ANI Pharmaceuticals competitorsClear all

ANI Pharmaceuticals's top competitors include Olainfarm and Merus.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
ANI Pharmaceuticals
ANI Pharmaceuticals
ANI Pharmaceuticals develops, manufactures and markets top quality prescription pharmaceuticals, made in the U.S.A.
Olainfarm
Olainfarm
Olainfarm manufactures and distributes chemical and pharmaceutical products primarily in Latvia.
Merus
Merus
Merus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics with the goal of treating and potentially curing cancer patients.
Founding Date
Founding Date
1996
Founding Date
1972
Founding Date
2003
Type
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
Baudette, US HQ
Oakville, CA
Baudette, US
Locations
Olaine, LV HQ
Locations
Utrecht, NL HQ
Cambridge, US
Employees
Employees
33813% increase
Employees
2,191
Employees
1893% increase
Valuation ($)
Valuation ($)
514.4 m
Valuation ($)
150.2 m
Valuation ($)
N/A
Alexa Website Rank
Alexa Website Rank
150691
Alexa Website Rank
110995
Alexa Website Rank
563795
Employee Rating
Employee Rating
3.5
Employee Rating
4.4
Employee Rating
4.2

Financial

Revenue (est.)
Revenue (est.)
$208.5m (FY, 2020)
Revenue (est.)
€124.3m (FY, 2018)
Revenue (est.)
N/A
Cost of goods
Cost of goods
$87.2m (FY, 2020)
Cost of goods
(€45.6m) (FY, 2018)
Cost of goods
N/A
Gross profit
Gross profit
$121.3m (FY, 2020)
Gross profit
€81.1m (FY, 2018)
Gross profit
N/A
Net income
Net income
($22.5m) (FY, 2020)
Net income
€10.7m (FY, 2018)
Net income
N/A
For sources of this data, please see the company profile

View company profiles

Olainfarm
HQ
Olaine, LV
Employees
2,191

Olainfarm manufactures and distributes chemical and pharmaceutical products primarily in Latvia.

View company
Merus
HQ
Utrecht, NL
Employees
189↑ 3% increase

Merus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics with the goal of treating and potentially curing cancer patients.

View company